Good MorningThe equities market continued its historic rally on Tuesday adding another 1.5% for most indices. The S&P 500 and Dow Jones Industrial Average are both trading firmly in new all-time high territory with the tech-heavy NASDAQ close behind. In broad terms, the market is still in a rotation from highly-valued tech names for more reasonably priced alternatives.
As bullish as the outlook is, traders should be wary of these new highs right before the holiday. Holiday-week trading volume is always light making any market move suspicious. Longer-term, however, there is a growing case for rising market value in 2021. Topping the list is economic rebound and earnings. The economic rebound is still going strong and the outlook for earnings gets brighter every day. Looking to the 4th quarter, there is a high probability S&P earnings will exit the pandemic recession and return to YOY growth.
Featured: Can A.I. Beat the Stock Market? (Vantage Point) 
|
Markets | | | The Analysts Upgrades Have Only Just Begun
The 3rd quarter earnings season is drawing to a close and with it, the analyst’s activity is beginning to heat up. The quarter was much better than expected for the broad S&P 500 and that means, for most companies, upgrades and price target incre... Read the Full Story |
|
From Our PartnersI call it my "Dividend Map", and I'll show you exactly where to find the safest companies that pay the highest yields. (HINT: Texas has 6 of these companies sending huge payouts that average 67%!). I'm willing to send you my Map... but only if you click here right now. If I don't have your name on my list in the next 2 hours, I'll assume you don't want to make monster dividends. | | Click here right now.
|
|
Markets | | |
These days, we are seeing more focus than ever before on renewable energy sources that can help to power our daily lives. While most of the headlines have been about electric vehicles and solar power, hydrogen energy is an intriguing alternative power source that has been available for years. The ... Read the Full Story |
|
Stocks | | |
Sometimes bad things happen to good companies. Whether due to market forces or company-specific issues this can mean high-quality companies go into a funk.
And when they do it can present opportunities to buy their stock when they are down but not out. Eventually, their financial strength enables... Read the Full Story |
|
From Our PartnersThis top gold stock of 2020 is gearing up to restart its flagship gold project in the US. It already has three million ounces of gold. This is an advanced-stage gold project that's being fast-tracked to production. Yet, Wall Street is once again asleep at the wheel as investors get in below $2 per share. With all the money-printing going on, gold and gold stocks are rising quickly. | | Learn More Here... |
|
Politics | | | Asian shares were mostly higher Tuesday, encouraged by news on the development of coronavirus vaccines and more assurance for a transition of power in the U.S. to President-elect Joe Biden.
The U.S. federal government recognized Biden as the “apparent winner” of the Nov. 3 election, ... Read the Full Story |
|
Politics | | | Global shares were mostly higher Tuesday, encouraged by news on the development of coronavirus vaccines and more assurance of a transition of power in the U.S. to President-elect Joe Biden.
The U.S. federal government recognized Biden as the “apparent winner” of the Nov. 3 election, ... Read the Full Story |
|
From Our PartnersIt trades under a secret name...for just $3.
But thanks to a developing situation involving Donald Trump, America's No. 1 tech company and $10 billion...this may soon be the most talked-about stock in America. | | Find out more about the "secret stock" here. |
|
Politics | | | Chinese Foreign Minister Wang Yi arrived in Japan on Tuesday to meet with his Japanese counterpart and discuss ways to revive their pandemic-hit economies as well as regional concerns over China’s growing influence.
During his two-day visit, Wang and Japanese Foreign Minister Toshimit... Read the Full Story |
|
Markets | | | A closely watched survey shows that business confidence in Germany, Europe’s biggest economy, fell for a second consecutive month in November as a resurgence of coronavirus infections led to partial shutdowns across the continent Read the Full Story |
|
Politics | | | Netflix plans to establish one of the largest production hubs in North America with an expansion of its existing studio complex in New Mexico and a commitment to an additional $1 billion in production spending, government and corporate leaders announced Monday.
Ten new stages, post-p... Read the Full Story |
|
Markets | | | Retail Trends Accelerate At Dick’s Sporting Goods
I have noticed a new trend developing among retailers. The retailers that have managed to survive and/or thrive during the pandemic. The stronger-than-expected rebound that began in the 2nd quarter is not only alive and well, but it is also ac... Read the Full Story |
|
Markets | | | The nation’s second-largest drugstore operator CVS Health (NYSE: CVS) stock got rug pulled on the rollout of Amazon Pharmacy (NASDAQ: AMZN). Shares of the pandemic benefactor had incredible momentum in the days leading up the announcement but are now underperforming the benchmark S&P 500 i... Read the Full Story |
|
The Early Bird Stock Of The Day Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson. | | View Today's Stock Pick |
|
